Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Down 88.6% in June

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a significant drop in short interest during the month of June. As of June 15th, there was short interest totaling 2,584 shares, a drop of 88.6% from the May 31st total of 22,688 shares. Based on an average daily volume of 98,688 shares, the short-interest ratio is currently 0.0 days.

Cardio Diagnostics Price Performance

CDIOW stock remained flat at $0.02 during trading on Friday. The firm has a 50 day moving average price of $0.02 and a 200-day moving average price of $0.02. Cardio Diagnostics has a 1 year low of $0.01 and a 1 year high of $0.07.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.